Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
18.83
-0.10 (-0.53%)
Aug 14, 2025, 11:56 AM - Market open

Korro Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
177357383--
Market Cap Growth
-62.66%-6.96%---
Enterprise Value
96229578--
Last Close Price
18.9338.0747.93--
PS Ratio
28.22157.04---
PB Ratio
1.542.222.26--
P/TBV Ratio
1.492.222.26--
EV/Sales Ratio
15.34100.98---
Debt / Equity Ratio
0.390.280.200.05-
Asset Turnover
0.030.01---
Quick Ratio
5.688.548.536.3523.95
Current Ratio
5.988.798.876.5624.20
Return on Equity (ROE)
-58.34%-50.60%-69.16%-62.24%-
Return on Assets (ROA)
-28.65%-25.65%-35.77%-36.63%-
Return on Capital (ROIC)
-31.09%-28.14%-38.98%-38.89%-
Earnings Yield
-53.32%-23.43%-21.18%--
FCF Yield
-43.11%-21.86%-19.60%--
Buyback Yield / Dilution
-65.89%-483.30%-499.32%94.26%-
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q